Prospective assessment of the impact of intraoperative diuretics in kidney transplant recipient surgery

  • 0From the Departments of Surgery (Levine, Rasmussen, Luke, Sener) and Microbiology & Immunology (Sener), Schulich School of Medicine & Dentistry, Western University, London, Ont.; the Matthew Mailing Centre for Translational Transplant Studies, London, Ont. (Lee, Rim, Farokhi, Luke, Sener); the Multi-Organ Transplant Program, London Health Sciences Centre, University Hospital, London, Ont. (Levine, Rasmussen, Luke, Sener); and the Division of Urology, Department of Surgery, University of Alberta, Edmonton, Alta. (Levine, Rasmussen).

Summary

This summary is machine-generated.

Intraoperative diuretics like furosemide or mannitol may reduce delayed graft function (DGF) after kidney transplantation. Pooled analysis showed a significant reduction in DGF when any diuretic was used compared to no diuretic.

Area Of Science

  • Nephrology
  • Transplantation Surgery
  • Pharmacology

Background

  • Delayed graft function (DGF) is a complication following kidney transplantation.
  • Intraoperative diuretics (furosemide, mannitol) are anecdotally used to prevent DGF, but evidence is limited.
  • Practice patterns for diuretic use in kidney transplantation vary significantly.

Purpose Of The Study

  • To evaluate the efficacy of intraoperative furosemide or mannitol in reducing DGF after kidney transplantation.
  • To compare DGF rates between patients receiving diuretics and those not receiving diuretics.
  • To assess secondary outcomes including graft function and potassium levels.

Main Methods

  • A cohort study design was employed.
  • Adult kidney transplant recipients were allocated to receive furosemide, mannitol, or no diuretic intraoperatively before reperfusion.
  • Primary outcome was DGF; secondary outcomes included 30-day graft function and perioperative potassium levels.

Main Results

  • 162 deceased donor kidney transplants were analyzed over two years.
  • No significant difference in DGF rates was observed between individual furosemide, mannitol, and control groups.
  • Pooled analysis of diuretic use (furosemide or mannitol) showed a significant reduction in DGF odds compared to the control group (OR 2.10, p=0.03).

Conclusions

  • Intraoperative administration of furosemide or mannitol may decrease the incidence of DGF in kidney transplant recipients.
  • The findings suggest a potential benefit of using intraoperative diuretics to improve early kidney graft outcomes.
  • A randomized controlled trial is recommended to confirm these findings and establish definitive evidence.

Related Concept Videos

Heart Failure Drugs: Diuretics 01:22

370

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...

Antihypertensive Drugs: Action of Diuretics 01:16

680

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...

Antihypertensive Drugs: Potassium-Sparing Diuretics 01:28

534

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...

Renal Failure: Dose Adjustments 01:11

88

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...

Dialysis 01:27

307

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...

Antihypertensive Drugs: Thiazide-Class Diuretics 01:15

624

Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...